Cargando…
Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists
PURPOSE: The treatment of retinopathy of prematurity (ROP) is not standardized and can vary significantly between providers. This study aims to determine preferred practices in treating ROP by globally surveying pediatric ophthalmologists. METHODS: Between January and February 2017, an international...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978463/ https://www.ncbi.nlm.nih.gov/pubmed/29881255 http://dx.doi.org/10.2147/OPTH.S161504 |
_version_ | 1783327532255281152 |
---|---|
author | Fouzdar Jain, Samiksha Song, Helen H Al-Holou, Shaza N Morgan, Linda A Suh, Donny W |
author_facet | Fouzdar Jain, Samiksha Song, Helen H Al-Holou, Shaza N Morgan, Linda A Suh, Donny W |
author_sort | Fouzdar Jain, Samiksha |
collection | PubMed |
description | PURPOSE: The treatment of retinopathy of prematurity (ROP) is not standardized and can vary significantly between providers. This study aims to determine preferred practices in treating ROP by globally surveying pediatric ophthalmologists. METHODS: Between January and February 2017, an international pediatric ophthalmology interest group was invited to complete an anonymous survey of 18 questions. The main objectives were to determine the preferred first line of treatment for ROP, the preferred dosage of intravitreal bevacizumab (IVB) used, and the outcome and possible complications following bevacizumab injection. RESULTS: Out of 101 pediatric ophthalmologists, 72 (71.8%) stated that they had direct involvement in the treatment of ROP. When presented with type 1 ROP which requires treatment, 69 ophthalmologists (68.3%) stated that they prefer laser treatment over bevacizumab, and 33 ophthalmologists (32.7%) stated they would recommend bevacizumab as a first choice. Ninety-three ophthalmologists (92.1%) reported the success of 1 laser treatment between 75% and 100%, and 35 ophthalmologists (34.7%) perceive bevacizumab to be 75%–100% successful. Half dose of adult-prescribed bevacizumab at 0.625 mg/0.05 mL was preferred by 47 of the ophthalmologists (46.5%). No cases of endophthalmitis were reported with intravitreal injection. CONCLUSION: Laser photoablation remains the preferred mode of treatment for ROP among surveyed ophthalmologists across the world. Though bevacizumab is currently being used, this form of treatment is not as common, primarily due to the unknown safety profile and potential long-term ramifications of the drug. |
format | Online Article Text |
id | pubmed-5978463 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-59784632018-06-07 Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists Fouzdar Jain, Samiksha Song, Helen H Al-Holou, Shaza N Morgan, Linda A Suh, Donny W Clin Ophthalmol Original Research PURPOSE: The treatment of retinopathy of prematurity (ROP) is not standardized and can vary significantly between providers. This study aims to determine preferred practices in treating ROP by globally surveying pediatric ophthalmologists. METHODS: Between January and February 2017, an international pediatric ophthalmology interest group was invited to complete an anonymous survey of 18 questions. The main objectives were to determine the preferred first line of treatment for ROP, the preferred dosage of intravitreal bevacizumab (IVB) used, and the outcome and possible complications following bevacizumab injection. RESULTS: Out of 101 pediatric ophthalmologists, 72 (71.8%) stated that they had direct involvement in the treatment of ROP. When presented with type 1 ROP which requires treatment, 69 ophthalmologists (68.3%) stated that they prefer laser treatment over bevacizumab, and 33 ophthalmologists (32.7%) stated they would recommend bevacizumab as a first choice. Ninety-three ophthalmologists (92.1%) reported the success of 1 laser treatment between 75% and 100%, and 35 ophthalmologists (34.7%) perceive bevacizumab to be 75%–100% successful. Half dose of adult-prescribed bevacizumab at 0.625 mg/0.05 mL was preferred by 47 of the ophthalmologists (46.5%). No cases of endophthalmitis were reported with intravitreal injection. CONCLUSION: Laser photoablation remains the preferred mode of treatment for ROP among surveyed ophthalmologists across the world. Though bevacizumab is currently being used, this form of treatment is not as common, primarily due to the unknown safety profile and potential long-term ramifications of the drug. Dove Medical Press 2018-05-25 /pmc/articles/PMC5978463/ /pubmed/29881255 http://dx.doi.org/10.2147/OPTH.S161504 Text en © 2018 Fouzdar Jain et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Fouzdar Jain, Samiksha Song, Helen H Al-Holou, Shaza N Morgan, Linda A Suh, Donny W Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists |
title | Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists |
title_full | Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists |
title_fullStr | Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists |
title_full_unstemmed | Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists |
title_short | Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists |
title_sort | retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978463/ https://www.ncbi.nlm.nih.gov/pubmed/29881255 http://dx.doi.org/10.2147/OPTH.S161504 |
work_keys_str_mv | AT fouzdarjainsamiksha retinopathyofprematuritypreferredpracticepatternsamongpediatricophthalmologists AT songhelenh retinopathyofprematuritypreferredpracticepatternsamongpediatricophthalmologists AT alholoushazan retinopathyofprematuritypreferredpracticepatternsamongpediatricophthalmologists AT morganlindaa retinopathyofprematuritypreferredpracticepatternsamongpediatricophthalmologists AT suhdonnyw retinopathyofprematuritypreferredpracticepatternsamongpediatricophthalmologists |